Zeo ScientifiX (ZEOX) Other Non-Current Assets (2014 - 2026)

Zeo ScientifiX (ZEOX) posted quarterly Other Non-Current Assets of $11000.0 for Q2 2026, up 57.14% quarter-over-quarter from $7000.0 in Q1 2024.

Zeo ScientifiX (ZEOX) Other Non-Current Assets (2014 - 2026) Analysis & Trends

Zeo ScientifiX's Other Non-Current Assets history runs 12 years deep, the most recent figure standing at $11000.0 for Q2 2026.

In Q2 2026, Other Non-Current Assets changed N/A year-over-year to $11000.0; the TTM figure through Apr 2026 stood at $11000.0 (changed N/A YoY), while the FY2023 annual figure was $7000.0, down 82.47% from the prior year.
Other Non-Current Assets for Q2 2026 stood at $11000.0, up from $7000.0 in the prior quarter.
The five-year high for Other Non-Current Assets was $226525.0 in Q1 2022, with the low at $7000.0 in Q4 2023.
The 4-year median for Other Non-Current Assets is $30400.0 (2023), against an average of $60124.4.
The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets surged 990.01% in 2022, then tumbled 86.58% in 2023.
Zeo ScientifiX's Other Non-Current Assets stood at $39936.0 in 2022, then sank by 82.47% to $7000.0 in 2023, then changed by 0.0% to $7000.0 in 2024, then jumped by 57.14% to $11000.0 in 2026.
Business Quant data shows ZEOX's Other Non-Current Assets at $11000.0 in Q2 2026, $7000.0 in Q1 2024, and $7000.0 in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Other Non-Current Assets (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	1.25 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	2.31 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	124.00 Mn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	618.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	109.58 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	65.13 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	202.31 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	104.44 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	62.96 Mn
10	Zeo ScientifiX	10.51 Mn	8.67 Mn	2.06 Mn	11,000.00

Download Data